TREPROSTINIL PALMITIL INHALATION POWDER, TREPROSTINIL PALMITIL INHALATION POWDER, Placebo (inhalation powder capsules) containing 1 of 3 dosage strengths of TPIP (80 μg, 160 μg, or 320 μg), TREPROSTINIL PALMITIL INHALATION POWDER
INS1009-203
Phase 3 small_molecule active
Quick answer
TREPROSTINIL PALMITIL INHALATION POWDER, TREPROSTINIL PALMITIL INHALATION POWDER, Placebo (inhalation powder capsules) containing 1 of 3 dosage strengths of TPIP (80 μg, 160 μg, or 320 μg), TREPROSTINIL PALMITIL INHALATION POWDER for Pulmonary Arterial Hypertension is a Phase 3 program (small_molecule) at Insmed Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Insmed Limited
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active